These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pneumocystis carinii infection among human immunodeficiency virus (HIV) infected Myanmar patients. Kay-Thwe-Han ; Rai-Mra ; Htin-Aung-Saw ; Ye-Htut ; Wynn-Naing Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):577-9. PubMed ID: 15115131 [TBL] [Abstract][Full Text] [Related]
6. Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992. Colford JM; Segal M; Tabnak F; Chen M; Sun R; Tager I Am J Epidemiol; 1997 Jul; 146(2):115-27. PubMed ID: 9230773 [TBL] [Abstract][Full Text] [Related]
7. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy. Ball SC AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976 [TBL] [Abstract][Full Text] [Related]
8. The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression. Butt AA; Michaels S; Kissinger P Int J Infect Dis; 2002 Sep; 6(3):178-81. PubMed ID: 12718831 [TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in HIV-infected patients. May TA; Gruta CI; Goldschmidt RH Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837 [No Abstract] [Full Text] [Related]
10. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Enomoto T; Azuma A; Kohno A; Kaneko K; Saito H; Kametaka M; Usuki J; Gemma A; Kudoh S; Nakamura S Respirology; 2010 Jan; 15(1):126-31. PubMed ID: 19947989 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E; N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138 [TBL] [Abstract][Full Text] [Related]
12. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627 [TBL] [Abstract][Full Text] [Related]
13. Features and outcome of Pneumocystis carinii pneumonia according to risk category for HIV infection. Laing R; Brettle R; Leen C; Hulks G Scand J Infect Dis; 1997; 29(1):57-61. PubMed ID: 9112299 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients]. Armbruster C; Hassl A; Kriwanek S Wien Klin Wochenschr; 1998 Sep; 110(17):604-7. PubMed ID: 9816629 [TBL] [Abstract][Full Text] [Related]
15. Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States. Dworkin MS; Hanson DL; Navin TR J Infect Dis; 2001 May; 183(9):1409-12. PubMed ID: 11294675 [TBL] [Abstract][Full Text] [Related]
16. Pneumocystis carinii pneumonia as the first presentation of HIV infection in patients older than fifty. Jedlovsky V; Fleischman JK AIDS Patient Care STDS; 2000 May; 14(5):247-9. PubMed ID: 10833811 [TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Graham SM; Mtitimila EI; Kamanga HS; Walsh AL; Hart CA; Molyneux ME Lancet; 2000 Jan; 355(9201):369-73. PubMed ID: 10665557 [TBL] [Abstract][Full Text] [Related]
18. Survival benefits of pulmonary cellular activation in AIDS patients with Pneumocystis infection. Sharma R; Herndon B; Dew M; Rosa U South Med J; 1997 May; 90(5):531-4. PubMed ID: 9160074 [TBL] [Abstract][Full Text] [Related]
19. Chronic Pneumocystis carinii pneumonia associated with extensive pneumatocele formation in a child with human immunodeficiency virus infection. Holland ET; Saulsbury FT Pediatr Pulmonol; 2003 Feb; 35(2):144-6. PubMed ID: 12526077 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group. Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]